Celularity Inc. (NASDAQ:CELUW) Short Interest Down 25.8% in September

Celularity Inc. (NASDAQ:CELUW) saw a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 30,700 shares, a drop of 25.8% from the August 31st total of 41,400 shares. Based on an average daily volume of 14,100 shares, the short-interest ratio is presently 2.2 days. Based on an average daily volume of 14,100 shares, the short-interest ratio is presently 2.2 days.

Celularity Stock Performance

Shares of Celularity stock opened at $0.03 on Tuesday. Celularity has a 1-year low of $0.01 and a 1-year high of $0.75. The firm has a fifty day simple moving average of $0.05 and a 200-day simple moving average of $0.05.

Celularity Company Profile

Celularity Inc, a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease.